JPRN-UMIN000011905已完成未知
Effect of carnitine supplementation on clinical outcomes in patients with heart failure with preserved ejection fraction - Effect of carnitine supplementation on clinical outcomes in patients with heart failure with preserved ejection fraction
Department of Molecular Medicine and Therapeutics, Tottori University0 个研究点目标入组 13 人开始时间: 2013年9月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 13
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with acute coronary syndrome, severe valve disease, congenital disease,pulmonary thrombosis, and primary pulmonary hypertention
研究者
相似试验
招募中
3 期
Effect of L-carnitine in Ischemic StrokeIschemic stroke.Cerebral infarctionIRCT20221206056734N1Ahvaz University of Medical Sciences82
招募中
3 期
The Effect of L-Carnitine supplementation administration rout on the prognosis of patientsPatients admitted to the intensive care unit.Follow-up examination after unspecified treatment for other conditionsZ09.9IRCT20170903036041N4Iran University of Medical Sciences135
已完成
2 期
The effect of L carnitine in women with knee osteoarthritisknee osteo arthritis.Primary generalized (osteo)arthrosisIRCT2017011932026N2Vice Chancellor for research of School of Public Health, Shahid Sadoughi University of Medical Scien76
已完成
不适用
Clinical effect of intravenous carnitine supplementation and the change of blood carnitine levels in hemodialysis patients:an observational studyChronic renal failureJPRN-UMIN000010962Department of Emergency and Critical Care Medicine, Chiba University, Graduate School of Medicine11
进行中（未招募）
不适用
Effects of L-carnitine administration in patients with elevated Lp(a)levels. - NDDislipidemic patients with Lp(a)>35 mg/dlLDL-C<190 mg/dl, TG<500 mg/dlMedDRA version: 9.1Level: LLTClassification code 10062060EUCTR2010-022041-19-ITRostaQuo S.p.A.